Zev A. Wainberg, MD | Authors

Zev A. Wainberg, MD, on Future Research Efforts for Patients With Advanced Gastric Cancer

February 07, 2022

Zev A. Wainberg, MD, discusses future research efforts for the treatment of patients with advanced gastric cancer.

Zev A. Wainberg, MD, Highlights the Rationale for Examining Long-Term Data From Pembrolizumab/Chemo in Advanced Gastric/GEJ Adenocarcinoma

January 29, 2022

Zev A. Wainberg, MD, spoke to the rationale for examining the efficacy of pembrolizumab alone and in combination with chemotherapy for patients with advanced gastric and gastroesophageal junction adenocarcinoma.

Zev A. Wainberg, MD, on Findings From the Updated KEYNOTE-062 Trial With Pembrolizumab/Chemo for Advanced Gastric/GEJ Adenocarcinoma

January 21, 2022

In an interview with CancerNetwork® during the 2022 Gastrointestinal Cancer Symposium, Zev A. Wainberg, MD, discussed key updates from the phase 3 KEYNOTE-062 trial, examining pembrolizumab plus or minus chemotherapy for patients with advanced gastric and gastroesophageal junction adenocarcinoma.